IMMUNE SYSTEM REGULATION HOLDING AB has a total of 40 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PRO NEURON INC, WU RONG-TSUN and ASTELLAS PHARMA EUROP B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | Canada | 8 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | United States | 6 | |
#6 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Winqvist Ola | 40 |
#2 | Moss Steven | 35 |
#3 | Gregory Matt | 34 |
#4 | Wallin Robert | 30 |
#5 | Lindh Emma | 30 |
#6 | Walin Robert | 4 |
#7 | Lind Emma | 4 |
#8 | Lundgren Yen | 4 |
Publication | Filing date | Title |
---|---|---|
WO2018153954A1 | Novel immune stimulating macrolide | |
EP3585795A1 | Novel immune stimulating macrolides | |
US2020010499A1 | Novel immune stimulating compound | |
CN110418799A | New compound (immunostimulatory peptides) |